Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04015687 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Effect of AG-881 on the Pharmacokinetics of a Single Dose of Lamotrigine in Healthy Adults
A Phase 1 study, sponsored by Agios Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT04015687 is a Phase 1 study that has completed, run by Agios Pharmaceuticals. The registered enrollment target is 22 participants.
The verdict
NCT04015687, a Phase 1 study, has completed, sponsored by Agios Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The main purpose of this study is to examine the effect of multiple doses of AG-881 on the pharmacokinetics (PK) of a single dose of lamotrigine in healthy adults.
Interventions
- DRUG Lamotrigine
- DRUG AG-881
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2019-10-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04015687
The ClinicalTrials.gov registry entry for NCT04015687 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Agios Pharmaceuticals, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lamotrigine is the first listed.
NCT04015687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04015687 about?
NCT04015687 is a clinical study titled "A Study to Evaluate the Effect of AG-881 on the Pharmacokinetics of a Single Dose of Lamotrigine in Healthy Adults". The main purpose of this study is to examine the effect of multiple doses of AG-881 on the pharmacokinetics (PK) of a single dose of lamotrigine in healthy adults.
What is the current status of trial NCT04015687?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2019-07-15. Estimated completion is 2019-10-09.
What interventions are being tested in trial NCT04015687?
The interventions under investigation include: Lamotrigine (DRUG), AG-881 (DRUG).
Who is sponsoring clinical trial NCT04015687?
This trial is sponsored by Agios Pharmaceuticals, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.